Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
|
|
Forian Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
8-K
| Completion of Acquisition or Disposition of Assets Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results|
Docs:
|
"Newtown, PA, May 12, 2023 – via NewMediaWire – Forian Inc. , a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended March 31, 2023. “As we continue our transition into a pure-play healthcare information company, Forian delivered another quarter of strong operational and financial performance,” stated Max Wygod, Chairman and Chief Executive Officer of Forian. Discontinued Operations As disclosed in its filings with the United States Securities and Exchange Commission , Forian completed the disposition of its cannabis software business on February 10, 2023. Through this transaction, and the previous dispositions in 2022 of Forian’s web design and security monitoring businesses, Forian..." |
|
| 03/27/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
8-K
| Quarterly results |
| 08/11/2022 |
8-K
| Quarterly results|
Docs:
|
"Newtown, PA / August 11, 2022 / Forian Inc. , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter ended June 30, 2022. “Forian delivered strong financial results in the second quarter, reflecting growing demand across our offerings,” said Max Wygod, Forian Executive Chairman. “The second quarter passed an inflection point in the business where we now see our growth directly driving towards substantial profitability.” Forian Chief Executive Officer Dan Barton continued, “Second quarter 2022 financial results built upon our momentum of strong sales of our subscription-based healthcare information offerings coupled with execution on cost management strategies.” Second Quarter 2022 Financial R..." |
|
| 06/21/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 04/08/2022 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 Interactive Data |
| 03/24/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Newtown, PA / March 24, 2022 / Forian Inc. , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the quarter and year ended December 31, 2021. “We have achieved many milestones in the last year” said Max Wygod, Forian Executive Chairman. “We have grown revenue tremendously, won key accounts, built out the Forian team and completed the acquisition of Helix Technologies, not to mention successfully listing on Nasdaq.” Forian Chief Executive Officer Dan Barton said, “We had our highest revenue quarter as a result of strong focus on sales execution and continued investment in innovative products. We are expecting continued revenue growth as we expand our customer base and product portfolio. I want to than..." |
|
| 03/15/2022 |
8-K
| Quarterly results |
| 12/30/2021 |
8-K
| Quarterly results |
| 11/12/2021 |
8-K
| Quarterly results|
Docs:
|
"Newtown, PA / November 11, 2021 / Forian Inc. , a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced results for the fiscal quarter ended September 30, 2021. “I am proud of the Forian team’s work to achieve our organic financial growth goals as we invest to better serve our clients in these dynamic markets,” said Max Wygod, Executive Chairman of Forian. “We are very pleased with the results we’ve achieved in the third quarter of 2021. We have continued to build on the momentum from previous quarters. Our revenue growth, especially in our software and information segment, allows us to responsibly invest in talent and product. We can reconfirm our top line guidance of $5.4 million to $5.7 million in fourth quarter r..." |
|
| 09/02/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
8-K
| Quarterly results |
| 05/17/2021 |
8-K
| Quarterly results |
| 04/13/2021 |
8-K
| Quarterly results |
| 04/06/2021 |
8-K/A
| Quarterly results |
| 03/02/2021 |
8-K
| Acquisition/merger/asset purchase announced |
|
|